Candel Therapeutics, Inc.
CADL· Nasdaq
Released May 12, 2022, before the open
10-Q filed May 12, 2022, 42 days after period end · 0000950170-22-009479
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Revenue | $31.00K | $31.00K |
| Net Income | -$874.00K | -$4.48M |
| EPS Diluted | -$0.03 | -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Candel Therapeutics, Inc. · CIK 1841387 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2022 · filed May 12, 2022 · 42 d after period end
+3.5% from the close of May 11, 2022 to the close of May 12, 2022, the first after the release.